"Eastern Interstellar Stem Cell Angel Fund launched, with a scale of 2 billion yuan."

On April 17, at the 2026 Zhangjiang Pharmaceutical Valley International Innovation Conference, Advance Therapy Forum and 2026 Shanghai Stem Cell Conference, the Oriental Interstellar Stem Cell Angel Fund was officially launched. The fund has a size of 2 billion yuan, led by Shanghai Tongjing Stem Cell Technology Co., Ltd., and jointly initiated by Shenzhen Qianhai Zhongli Equity Investment Fund Management Co., Ltd., Shanghai Nanqin Investment Management Co., Ltd., and Zhejiang Tianma Industrial Co., Ltd. The fund focuses on stem cell frontier technologies, anti-aging intervention mechanisms, and related upstream and downstream high-barrier projects, aiming to build an industrial investment ecosystem.